Doxycycline and alcohol
Media coverage of clinical trials does not contain the elements readers require to make informed decisions. A comparison of the coverage received by pharmaceutical and herbal remedy trials, reported in the open access journal BMC Medicine, has revealed that it is rarely possible for the lay public to assess the credibility of the described research.
Full Post: Misleading media coverage of clinical trials
The serum levels of doxycycline may fall below minimal therapeutic concentrations in alcoholic patients, but tetracycline itself is not affected and it seems likely that the other tetracyclines are also not affected. There is nothing to suggest that moderate amounts of alcohol will significantly affect the serum levels of doxycycline or any other tetracycline in normal nonalcoholic subjects.
In a comparative study the half-life of doxycycline was found to be 10 5 h in six alcoholics compared with 14 7 h in six normal healthy volunteers The serum levels of two of the alcoholic patients fell well below what is generally accepted as the minimum therapeutic concentrations The half-life of tetracycline was the same in both groups All of them were given 100 mg doxycycline daily after a 200 mg loading dose, and 500 mg tetracycline twice daily after an initial 750 mg loading dose.
In another study in normal subjects it was found that cheap red wine (but not whiskey) postponed the absorption of doxycycline, probably because of the acetic acid content which slows gastric emptying, but did not affect its total absorption The authors concluded that the acute intake of alcoholic beverages generally does not interfere with the kinetics of doxycycline to an extent which would jeopardise therapeutic levels in tissues.
Heavy drinkers can metabolize some drugs much more quickly than non-drinkers due to the enzyme inducing effects of alcohol, and this interaction with doxycycline would seem to be due to this effect, possibly associated with some reduction in absorption from the gut.
Importance and management
Information is limited, but the doxycycline-alcohol interaction appears to be established It seems to be clinically significant in alcoholic subjects but not m normal individuals One suggested solution to the problem is to dose alcoholic subjects twice daily instead of only once. Alternatively tetra-cycline could be used because it appears not to be affected. There is nothing to suggest that moderate or even occasional heavy drinking affects any of the tetracylines in normal subjects.
See also: www.buydoxycycline.org.
Doxycycline fights bacteria in the body. It is used to treat urinary tract infections, gonorrhea, acne, gum disease and so on. You need to take it exactly as it was prescribed for you. It is good to drink it at the same time for a maximum effect. Continue using of Doxycycline even if in a few
Full Post: Doxycycline fights bacteria in the body
Two pregnancies and six cases of intermenstrual bleeding have been described in women using oral contraceptives, attributed to the use of Diflucan. This interaction (if such it is) is rare. Two pregnancies have been reported, despite the use of oral contraceptives, attributed to an interaction with single 150 mg doses of Diflucan. Intermenstrual bleeding has also
Full Post: Diflucan and oral contraceptives
Genaera Corporation has announced that dosing of subjects has begun in study MSI-1436C-102 (Study 102), the multiple ascending dose Phase 1b study of trodusquemine (MSI-1436) in overweight and obese type 2 diabetics. MSI-1436 is a novel therapeutic for the treatment of type 2 diabetes and obesity which works centrally and peripherally to regulate insulin and
Full Post: Genaera starts trial of Trodusquemine in overweight and obese type 2 diabetes
A secondary analysis of a large, multicenter clinical trial has shown that a diet loaded with fruits, vegetables and fiber and somewhat lower in fat compared to standard federal dietary recommendations cuts the risk of recurrence in a subgroup of early-stage breast cancer survivors - women who didn’t have hot flashes - by approximately 31
Full Post: Fruits, vegetables and fiber may cut risk of breast cancer recurrence in women without hot flashes
Raptor Pharmaceuticals Corp. has announced positive results in its Phase IIa study of oral 4-methylpyrazole (”4-MP”) in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program. Convivia is Raptor’s proprietary oral formulation of 4-MP designed to reduce systemic acetaldehyde exposure and related symptoms in ALDH2 deficient persons following
Full Post: Raptor Pharmaceuticals announces positive results for Convivia program